REFERENCES
- Carroll W L, Bhojwani D, Min D J. Pediatric acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2003; 102–131, [CSA]
- Pui C H, Relling M V, Downing J R. Mechanisms of disease: acute lymphoblastic leukemia. N Engl J Med. 2004; 350: 1535–1548, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schrappe M, Reiter A, Ludwig W D. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German–Austrian–Swiss ALL-BFM study group. Blood. 2000; 95: 3310–3322, [PUBMED], [INFOTRIEVE], [CSA]
- Silverman L B, Gelber R D, Dalton V K. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001; 97: 1211–1218, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pui C H, Ribeiro R C. International collaboration on childhood leukemia. Int J Hematol. 2003; 78: 383–389, [PUBMED], [INFOTRIEVE], [CSA]
- Metzger M L, Howard S C, Fu L C. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet. 2003; 362: 706–708, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hoelzer D, Gokbuget N, Ottmann O. Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2002; 162–192, [CSA]
- Smith M, Arthur D, Camitta B. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996; 14: 18–24, [PUBMED], [INFOTRIEVE], [CSA]
- Qiu J, Gunaratne P, Peterson L E. Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR. Leukemia. 2003; 17: 1891–1900, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ross M E, Zhou X, Song G. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003; 102: 2951–2959, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hayashi Y. Gene expression profiling in childhood acute leukemia: progress and perspectives. Int J Hematol. 2003; 78: 414–420, [PUBMED], [INFOTRIEVE], [CSA]
- Chiaretti S, Li X, Gentleman R. Gene expression profile of adult T-cell acute lymphoblastic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood. 2004; 103: 2771–2778, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- http://www.who.int/whr2001/2001/archives/2000/en/pdf/Annex1-en.pdf
- Al-Riyami A, Ebrahim G J. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003; 49: 11–20, Suppl 1[CSA]
- Brown L C, Knox-Macaulay H H. Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman. Leuk Res. 2003; 27: 649–654, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Al-Lamki Z, Wali Y A, Wasifuddin S M. Relapsed acute leukemia in children: Oman experience. Pediatr Hematol/Oncol. 2004; 21: 167–173, [CSA], [CROSSREF]
- Gaynon P S, Bostrom B C, Hutchinson R J. Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies. J Clin Oncol. 2001; 19: 1916–1925, [PUBMED], [INFOTRIEVE], [CSA]
- Jonsson V, Hansen M M, Ljungman P. Pharmacoeconomic considerations in treating patients with acute leukemia. Pharmacoeconomics. 1999; 15: 167–178, [PUBMED], [INFOTRIEVE], [CSA]
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156–159, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diatchenko L, Lau Y F, Campbell A P. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA. 1996; 93: 6025–6030, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gurskaya N G, Diatchenko L, Chenchik A. Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal Biochem. 1996; 240: 90–97, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gingras M C, Margolin J F. Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hyberdization. Exp Hematol. 2000; 28: 65–76, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCTmethod. Methods. 2001; 25: 402–408, [PUBMED], [CSA], [CROSSREF]
- Peterson L E. Factor analysis of cluster-specific gene expression levels from cDNA microarrays. Comp Methods Prog Biomed. 2002; 69: 179–188, [CSA], [CROSSREF]
- Peterson L E. Software Report: CLUSFAVOR 5.0: hierarchical cluster and principal component analysis of microarray-based transcriptional profiles. Genome Biol. 2002; 3, software 0002.1–0002.8[CSA]
- Smyth M J, Trapani J A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today. 1995; 76: 202–206, [CSA], [CROSSREF]
- Baker E, Sayers T J, Sutherland G R. The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11-q12 and define a new locus for cytotoxic lymphocyte granule tryptases. Immunogenetics. 1994; 40: 235–237, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sattar R, Ali S A, Abbasi A. Bioinformatics of granzymes: sequence comparison and structural studies on granzyme family by homology modeling. Biochem Biophys Res Commun. 2003; 308: 726–735, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yamada M, Hirasawa A, Shiojima S, Granzyme A. mediates glucocorticoid-induced apoptosis in leukemia cells. FASEB J. 2003; 17: 1712–1714, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Debatin K M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004; 53: 153–159, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hu W, Kavanagh J J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003; 4: 721–729, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stevenson D, Laverty H G, Wenwieser S. Mapping and expression analysis of the human CASK gene. Mamm Genome. 2000; 11: 934–937, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dimitratos S D, Woods D F, Stathakis D G. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays. 1999; 21: 912–921, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bredt D S. Cell biology. Reeling CASK into the nucleus. Nature. 2000; 404: 241–242, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma. Cancer Lett. 2002; 179: 71–77, [CSA], [CROSSREF]
- Ryu S, Zhou S, Ladurner A G. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature. 1999; 397: 446–450, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kikkawa E, Hinata M, Keng V W. Sp family members stimulate transcription of the hex gene via interactions with GC boxes. J Biochem (Tokyo). 2001; 130: 885–891, [CSA]
- George A, Morse H C, 3rd, Justice M J. The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells. Oncogene. 2003; 22: 6764–6773, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hansen G M, Justice M J. Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. Oncogene. 1999; 18: 6531–6539, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lo Nigro L, Cazzaniga G, Di Catalgo A. Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis. Leukemia. 1999; 13: 190–195, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol 2004; 83: S121–S123, Suppl 1[PUBMED], [INFOTRIEVE], [CSA]
- Tschentscher F, Prescher G, Horsman D E. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res. 2001; 61: 3439–3442, [PUBMED], [INFOTRIEVE], [CSA]
- Kettunen E, el-Rifai W, Bjorkqvist A M. A broad amplification pattern at 3q in squamous cell lung cancer—a fluorescence in situ hybridization study. Cancer Genet Cytogenet. 2000; 117: 66–70, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morishita K, Parganas E, Bartholomew C. The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(25;q34) translocations. Oncogene Res. 1990; 5: 221–231, [PUBMED], [INFOTRIEVE], [CSA]